Leveraging Multi-Analyte Liquid Biopsy to Reveal Novel Insights into Treatment Response & MRD Assessment
Time: 11:30 am
day: Conference Day 2
Details:
- Demonstrating the utility of CTCs for biomarker-driven treatment selection and monitoring
- How can we leverage more sensitive assays to enhance CTC applications in the early setting? The cellular residual disease (CRD) concept
- What can a multi-analyte approach offer in the context of MRD detection? Combining MRD and CRD
Novel Analyte
